Radiation Oncology

Papers
(The median citation count of Radiation Oncology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Radiotherapy and the gut microbiome: facts and fiction106
Current status and recent advances in reirradiation of glioblastoma104
Risk factors for osteoradionecrosis of the jaw in patients with head and neck squamous cell carcinoma83
Radiation-induced kidney toxicity: molecular and cellular pathogenesis73
Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations67
Implementation of deep learning-based auto-segmentation for radiotherapy planning structures: a workflow study at two cancer centers47
Recent advances in (chemo-)radiation therapy for rectal cancer: a comprehensive review45
Deep learning method for prediction of patient-specific dose distribution in breast cancer43
Radiotherapy of oligometastatic prostate cancer: a systematic review41
The watch-and-wait strategy versus surgical resection for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy41
Feasibility of Conebeam CT-based online adaptive radiotherapy for neoadjuvant treatment of rectal cancer38
Clinical feasibility of deep learning-based auto-segmentation of target volumes and organs-at-risk in breast cancer patients after breast-conserving surgery36
Interobserver variability in organ at risk delineation in head and neck cancer36
Current status and recent advances in resection cavity irradiation of brain metastases35
The basis and advances in clinical application of boron neutron capture therapy34
Radiation-induced senescence: therapeutic opportunities31
Evaluation of a treatment planning system developed for clinical boron neutron capture therapy and validation against an independent Monte Carlo dose calculation system31
Radiosensitization of breast cancer cells using AS1411 aptamer-conjugated gold nanoparticles31
Benefit of replanning in MR-guided online adaptive radiation therapy in the treatment of liver metastasis30
Generating synthetic CT from low-dose cone-beam CT by using generative adversarial networks for adaptive radiotherapy29
68Ga-DOTATATE PET-CT as a tool for radiation planning and evaluating treatment responses in the clinical management of meningiomas29
A review of radiomics and genomics applications in cancers: the way towards precision medicine28
Dosimetric benefit of MR-guided online adaptive radiotherapy in different tumor entities: liver, lung, abdominal lymph nodes, pancreas and prostate28
Clinical validation of a commercially available deep learning software for synthetic CT generation for brain28
Adjuvant radiotherapy versus observation following gross total resection for atypical meningioma: a systematic review and meta-analysis28
Impact of superparamagnetic iron oxide nanoparticles on in vitro and in vivo radiosensitisation of cancer cells28
Delta radiomics analysis of Magnetic Resonance guided radiotherapy imaging data can enable treatment response prediction in pancreatic cancer27
Patient positioning and immobilization procedures for hybrid MR-Linac systems27
Radiotherapy modulates tumor cell fate decisions: a review26
Development and validation of a radiomics-based model to predict local progression-free survival after chemo-radiotherapy in patients with esophageal squamous cell cancer26
Evaluation of auto-segmentation accuracy of cloud-based artificial intelligence and atlas-based models25
Developing an accurate model of spot-scanning treatment delivery time and sequence for a compact superconducting synchrocyclotron proton therapy system25
Explainable AI for CNN-based prostate tumor segmentation in multi-parametric MRI correlated to whole mount histopathology25
The roles of CC chemokines in response to radiation25
FET-PET radiomics in recurrent glioblastoma: prognostic value for outcome after re-irradiation?25
Deep-inspirational breath-hold (DIBH) technique in left-sided breast cancer: various aspects of clinical utility25
The impact of pelvic radiotherapy on the gut microbiome and its role in radiation-induced diarrhoea: a systematic review24
Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer23
Evaluation of deep learning-based autosegmentation in breast cancer radiotherapy23
Real-time liver tracking algorithm based on LSTM and SVR networks for use in surface-guided radiation therapy22
Accelerated coronary calcium burden in breast cancer patients after radiotherapy: a comparison with age and race matched healthy women21
Clinical features, treatment and outcomes in patients with tracheal adenoid cystic carcinoma: a systematic literature review21
Machine learning models predict overall survival and progression free survival of non-surgical esophageal cancer patients with chemoradiotherapy based on CT image radiomics signatures21
Predicting factors of symptomatic radiation pneumonitis induced by durvalumab following concurrent chemoradiotherapy in locally advanced non-small cell lung cancer21
Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the ‘TOaSTT’ database21
Risk factors for radiation pneumonitis in lung cancer patients with subclinical interstitial lung disease after thoracic radiation therapy20
MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial20
Combining losartan with radiotherapy increases tumor control and inhibits lung metastases from a HER2/neu-positive orthotopic breast cancer model20
Outcomes of metastasis-directed therapy of bone oligometastatic prostate cancer19
Review of cone beam computed tomography based online adaptive radiotherapy: current trend and future direction19
Dosimetric study between a single isocenter dynamic conformal arc therapy technique and Gamma Knife radiosurgery for multiple brain metastases treatment: impact of target volume geometrical characteri19
The feasibility of a dose painting procedure to treat prostate cancer based on mpMR images and hierarchical clustering19
Clinical implementation of magnetic resonance imaging simulation for radiation oncology planning: 5 year experience19
Preoperative hypofractionated radiotherapy for soft tissue sarcomas: a systematic review18
Radiation pneumonitis in patients with non-small-cell lung cancer receiving chemoradiotherapy and an immune checkpoint inhibitor: a retrospective study18
MR-guided SBRT boost for patients with locally advanced or recurrent gynecological cancers ineligible for brachytherapy: feasibility and early clinical experience18
Impact of feature selection methods and subgroup factors on prognostic analysis with CT-based radiomics in non-small cell lung cancer patients18
Effect of intrafraction adaptation on PTV margins for MRI guided online adaptive radiotherapy for rectal cancer18
Technical assessment of the NDI Polaris Vega optical tracking system18
Prognostic value of tumor measurement parameters and SCC-Ag changes in patients with locally-advanced cervical cancer18
The dosimetric impact of deep learning-based auto-segmentation of organs at risk on nasopharyngeal and rectal cancer18
MR-guided stereotactic body radiation therapy for primary cardiac sarcomas17
A dosimetric and radiobiological evaluation of VMAT following mastectomy for patients with left-sided breast cancer17
Therapeutic outcome and related predictors of stereotactic body radiotherapy for small liver-confined HCC: a systematic review and meta-analysis of observational studies17
Dosimetric impact of deep learning-based CT auto-segmentation on radiation therapy treatment planning for prostate cancer17
Radiomics for prediction of radiation-induced lung injury and oncologic outcome after robotic stereotactic body radiotherapy of lung cancer: results from two independent institutions16
Oligometastatic head and neck cancer: Which patients benefit from radical local treatment of all tumour sites?16
Comparing biological effectiveness guided plan optimization strategies for cranial proton therapy: potential and challenges16
Efficacy of radiotherapy for gastric bleeding associated with advanced gastric cancer16
Dosimetric analysis of local failures in skull-base chordoma and chondrosarcoma following pencil beam scanning proton therapy15
Single-isocenter multiple-target stereotactic radiosurgery for multiple brain metastases: dosimetric evaluation of two automated treatment planning systems15
Axitinib in combination with radiotherapy for advanced hepatocellular carcinoma: a phase I clinical trial15
Overlap time is an independent risk factor of radiation pneumonitis for patients treated with simultaneous EGFR-TKI and thoracic radiotherapy15
Deep learning in CT image segmentation of cervical cancer: a systematic review and meta-analysis15
Hypofractionated proton beam radiotherapy in patients with unresectable liver tumors: multi-institutional prospective results from the Proton Collaborative Group15
Radiation pneumonitis prediction after stereotactic body radiation therapy based on 3D dose distribution: dosiomics and/or deep learning-based radiomics features14
Applicability of a pathological complete response magnetic resonance-based radiomics model for locally advanced rectal cancer in intercontinental cohort14
Outcomes and prognostic factors in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy14
Sintilimab, stereotactic body radiotherapy and granulocyte–macrophage colony stimulating factor as second-line therapy for advanced non-small cell lung cancer: safety run-in results of a multicenter, 14
The first reported case of a patient with pancreatic cancer treated with cone beam computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR)14
Role of stereotactic body radiation in the enhancement of the quality of life in locally advanced pancreatic adenocarcinoma: a systematic review14
Local control of bone metastases treated with external beam radiotherapy in recent years: a multicenter retrospective study14
A clinical study of curative partial breast irradiation for stage I breast cancer using carbon ion radiotherapy14
Surgical spacer placement for proton radiotherapy in locally advanced pancreatic body and tail cancers: initial clinical results14
A prospective study investigating the efficacy and toxicity of definitive ChemoRadiation and ImmunOtherapy (CRIO) in locally and/or regionally advanced unresectable cutaneous squamous cell carcinoma14
Medical student education through flipped learning and virtual rotations in radiation oncology during the COVID-19 pandemic: a cross sectional research13
Clinical outcome and pathologic correlation of stereotactic body radiation therapy as a bridge to transplantation for advanced hepatocellular carcinoma: a case series13
Simultaneous radiosurgery for multiple brain metastases: technical overview of the UCLA experience13
Efficacy and safety of carbon ion radiotherapy for bone sarcomas: a systematic review and meta-analysis13
Comparison of liver exposure in CT-guided high-dose rate (HDR) interstitial brachytherapy versus SBRT in hepatocellular carcinoma13
CT radiomics-based long-term survival prediction for locally advanced non-small cell lung cancer patients treated with concurrent chemoradiotherapy using features from tumor and tumor organismal envir13
Proton therapy with a fixed beamline for skull-base chordomas and chondrosarcomas: outcomes and toxicity13
Clinical application of MR-Linac in tumor radiotherapy: a systematic review13
Optimal stereotactic body radiotherapy dosage for hepatocellular carcinoma: a multicenter study13
Pediatric craniospinal irradiation with a short partial-arc VMAT technique for medulloblastoma tumors in dosimetric comparison13
Multifocal high-grade glioma radiotherapy safety and efficacy13
Magnetic resonance guided adaptive stereotactic body radiotherapy for lung tumors in ultracentral location: the MAGELLAN trial (ARO 2021-3)13
Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial13
A deep image-to-image network organ segmentation algorithm for radiation treatment planning: principles and evaluation13
Lung stereotactic body radiation therapy for elderly patients aged ≥ 80 years with pathologically proven early-stage non-small cell lung cancer: a retrospective cohort study12
Operating procedures, risk management and challenges during implementation of adaptive and non-adaptive MR-guided radiotherapy: 1-year single-center experience12
Cone beam CT-based dose accumulation and analysis of delivered dose to the dominant intraprostatic lesion in primary radiotherapy of prostate cancer12
Treatment planning comparison of volumetric modulated arc therapy with the trilogy and the Halcyon for bilateral breast cancer12
Simulation CT-based radiomics for prediction of response after neoadjuvant chemo-radiotherapy in patients with locally advanced rectal cancer12
Outcome of early stage Merkel carcinoma treated by exclusive radiation: a study of 53 patients12
Interfractional target changes in brain metastases during 13-fraction stereotactic radiotherapy12
Apparent diffusion coefficient for the prediction of tumor response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer12
Salvage re-irradiation using stereotactic body radiation therapy for locally recurrent prostate cancer: the impact of castration sensitivity on treatment outcomes12
Report on planning comparison of VMAT, IMRT and helical tomotherapy for the ESCALOX-trial pre-study12
Stereotactic body radiotherapy versus conventional radiotherapy for painful bone metastases: a systematic review and meta-analysis of randomised controlled trials11
MR-guided radiotherapy in node-positive non-small cell lung cancer and severely limited pulmonary reserve: a report proposing a new clinical pathway for the management of high-risk patients11
Biological dosiomic features for the prediction of radiation pneumonitis in esophageal cancer patients11
Diffusion-weighted MRI and 18F-FDG PET/CT in assessing the response to neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma11
High dose simultaneous integrated boost for node positive cervical cancer11
Organs-at-risk dose constraints in head and neck intensity-modulated radiation therapy using a dataset from a multi-institutional clinical trial (JCOG1015A1)11
Pattern of failure in prostate cancer previously treated with radical prostatectomy and post-operative radiotherapy: a secondary analysis of two prospective studies using novel molecular imaging techn11
Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible11
Primary tumor volume and prognosis for patients with p16-positive and p16-negative oropharyngeal squamous cell carcinoma treated with radiation therapy11
Stereotactic body radiotherapy extends the clinical benefit of PD-1 inhibitors in refractory recurrent/metastatic nasopharyngeal carcinoma11
Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities11
Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT)11
Clinical outcomes of extensive-stage small cell lung cancer patients treated with thoracic radiotherapy at different times and fractionations11
Therapeutic effect of osimertinib plus cranial radiotherapy compared to osimertinib alone in NSCLC patients with EGFR-activating mutations and brain metastases: a retrospective study11
RBE-weighted dose conversions for patients with recurrent nasopharyngeal carcinoma receiving carbon-ion radiotherapy from the local effect model to the microdosimetric kinetic model10
MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clin10
The decreased mean platelet volume is associated with poor prognosis in patients with oropharyngeal cancer treated with radiotherapy10
Online MR evaluation of inter- and intra-fraction uterus motions and bladder volume changes during cervical cancer external beam radiotherapy10
Geometric and dosimetric impact of 3D generative adversarial network-based metal artifact reduction algorithm on VMAT and IMPT for the head and neck region10
Comparison of the composition of lymphocyte subpopulations in non-relapse and relapse patients with squamous cell carcinoma of the head and neck before, during radiochemotherapy and in the follow-up p10
A deep learning-based self-adapting ensemble method for segmentation in gynecological brachytherapy10
Investigating the potential of proton therapy for hypoxia-targeted dose escalation in non-small cell lung cancer10
Complete response to neoadjuvant chemoradiotherapy in rectal cancer is associated with RAS/AKT mutations and high tumour mutational burden10
Long-term outcome after combined kyphoplasty and intraoperative radiotherapy (Kypho-IORT) for vertebral tumors10
A meta-analysis of the efficacy and safety of accelerated partial breast irradiation versus whole-breast irradiation for early-stage breast cancer10
Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer10
Whole-brain irradiation differentially modifies neurotransmitters levels and receptors in the hypothalamus and the prefrontal cortex10
Topographic distribution of lymph node metastasis in patients with stage IB1 cervical cancer: an analysis of 8314 lymph nodes9
Comparison of 5 × 5 Gy and 10 × 3 Gy for metastatic spinal cord compression using data from three prospective trials9
Simultaneous integrated boost concepts in definitive radiation therapy for esophageal cancer: outcomes and toxicity9
Clinical predictors of pathological good response in locally advanced rectal cancer9
Unplanned hospitalizations in patients with locoregionally advanced head and neck cancer treated with (chemo)radiotherapy with and without prophylactic percutaneous endoscopic gastrostomy9
Predicting survival in anaplastic astrocytoma patients in a single-center cohort of 108 patients9
Treatment outcome and compliance to dose-intensified linac-based SBRT for unfavorable prostate tumors using a novel real-time organ-motion tracking9
Radiosurgery of limited brain metastases from primary solid tumor: results of the randomized phase III trial (NCT02355613) comparing treatments executed with a specialized or a C-arm linac-based platf9
Predictors of osteoradionecrosis following irradiated tooth extraction9
Stereotactic body radiotherapy in combination with non-frontline PD-1 inhibitors and targeted agents in metastatic renal cell carcinoma9
Omitting surgery in esophageal cancer patients with complete response after neoadjuvant chemoradiotherapy: a systematic review and meta-analysis9
Differential effects of radiation fractionation regimens on glioblastoma9
Deep learning-based automatic delineation of the hippocampus by MRI: geometric and dosimetric evaluation9
Effects of whole-brain radiation therapy on the blood–brain barrier in immunocompetent and immunocompromised mouse models9
Outcome of intracerebral cavernoma treated by Gamma Knife radiosurgery based on a double-blind assessment of treatment indication9
Benefit of chemotherapy based on platinum with definitive radiotherapy in older patients with locally advanced esophageal squamous cell carcinoma8
Synthetic contrast-enhanced computed tomography generation using a deep convolutional neural network for cardiac substructure delineation in breast cancer radiation therapy: a feasibility study8
Radiotherapeutic treatment options for oligotopic malignant liver lesions8
Predictors of radiation-induced hypothyroidism in nasopharyngeal carcinoma survivors after intensity-modulated radiotherapy8
Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and 18F-FDG PET/CT for radiotherapy target volume definition8
Clinical utility of Gafchromic film in an MRI-guided linear accelerator8
An interpretable radiomics model to select patients for radiotherapy after surgery for WHO grade 2 meningiomas8
Interobserver variability in target volume delineation in definitive radiotherapy for thoracic esophageal cancer: a multi-center study from China8
A cycle generative adversarial network for improving the quality of four-dimensional cone-beam computed tomography images8
Applications of various range shifters for proton pencil beam scanning radiotherapy8
Modern treatment outcomes for early T-stage oropharyngeal cancer treated with intensity-modulated radiation therapy at a tertiary care institution8
Variability of α/β ratios for prostate cancer with the fractionation schedule: caution against using the linear-quadratic model for hypofractionated radiotherapy8
Establishment of prognostic models for adenocarcinoma of oesophagogastric junction patients with neoadjuvant chemoradiotherapy: a real-world study8
Clinical evaluation of two AI models for automated breast cancer plan generation8
Clinical adoption patterns of 0.35 Tesla MR-guided radiation therapy in Europe and Asia8
Radiotherapy treatment modification for prostate cancer patients based on PSMA-PET/CT8
Cranial organs at risk delineation: heterogenous practices in radiotherapy planning8
Imaging biomarkers of contrast-enhanced computed tomography predict survival in oesophageal cancer after definitive concurrent chemoradiotherapy8
A dual deep neural network for auto-delineation in cervical cancer radiotherapy with clinical validation8
Long-term outcomes of SBRT for PSMA PET detected oligometastatic prostate cancer8
Personalising treatment plan quality review with knowledge-based planning in the TROG 15.03 trial for stereotactic ablative body radiotherapy in primary kidney cancer8
Molecular features of glioblastomas in long-term survivors compared to short-term survivors—a matched-pair analysis8
Investigation of the clinical inter-observer bias in prostate fiducial marker image registration between CT and MR images8
Gastrointestinal and genitourinary toxicity profiles of metformin versus placebo in men with prostate cancer receiving prostate radiotherapy: interim toxicity results of a double-blinded, multicenter,8
Strategies to improve deep learning-based salivary gland segmentation8
Validation of an MRI-only planning workflow for definitive pelvic radiotherapy8
Stratified assessment of an FDA-cleared deep learning algorithm for automated detection and contouring of metastatic brain tumors in stereotactic radiosurgery8
Stereotactic radiosurgery for treating meningiomas eligible for complete resection8
Prognostic value of tumor-infiltrating immune cells and immune checkpoints in elderly head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiotherapy8
Efficacy and safety of radiotherapy plus anti-PD1 versus transcatheter arterial chemoembolization plus sorafenib for advanced hepatocellular carcinoma: a real-world study8
Phase II study of stereotactic body radiotherapy with hydrogel spacer for prostate cancer: acute toxicity and propensity score-matched comparison8
Stereotactic body radiation therapy for the treatment of localized prostate cancer in men with underlying inflammatory bowel disease8
Automatic segmentation of vestibular schwannomas from T1-weighted MRI with a deep neural network8
Appropriate margin for planning target volume for breast radiotherapy during deep inspiration breath-hold by variance component analysis7
Fiducial-based image-guided SBRT for pancreatic adenocarcinoma: Does inter-and intra-fraction treatment variation warrant adaptive therapy?7
Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma7
Vertebral body and splenic irradiation are associated with lymphopenia in localized pancreatic cancer treated with stereotactic body radiation therapy7
Glioblastoma radiotherapy using Intensity modulated Radiotherapy (IMRT) or proton Radiotherapy—GRIPS Trial (Glioblastoma Radiotherapy via IMRT or Proton BeamS): a study protocol for a multicenter, pro7
Hypofractionated intensity-modulated radiotherapy with concurrent chemotherapy for elderly patients with locally advanced pancreatic carcinoma7
Developing and validating an integrated gross tumor volume (GTV)-TNM stratification system for supplementing unresectable locally advanced non-small cell lung cancer treated with concurrent chemoradio7
Efficacy of concurrent chemoradiotherapy in subgroups of stage III nasopharyngeal carcinoma: an analysis based on 10-year follow-up7
Estimating the tolerance of brachial plexus to hypofractionated stereotactic body radiotherapy: a modelling-based approach from clinical experience7
Preoperative spirometry and BMI in deep inspiration breath-hold radiotherapy: the early detection of cardiac and lung dose predictors without radiation exposure7
Improving the efficacy of combined radiotherapy and immunotherapy: focusing on the effects of radiosensitivity7
Determining optimal clinical target volume margins in high-grade glioma based on microscopic tumor extension and magnetic resonance imaging7
Role of postoperative radiotherapy in resected adenoid cystic carcinoma of the head and neck7
Cardiac-sparing radiotherapy for locally advanced non-small cell lung cancer7
Adjuvant therapy for retroperitoneal sarcoma: a meta-analysis7
Stereotactic radiosurgery of benign brain tumors in elderly patients: evaluation of outcome and toxicity7
Association of neutrophil-to-lymphocyte ratio, radiotherapy fractionation/technique, and risk of development of distant metastasis among patients with locally advanced rectal cancer7
Ventilation and perfusion MRI at a 0.35 T MR-Linac: feasibility and reproducibility study7
Delayed postoperative radiotherapy increases the incidence of radiographic local tumor progression before radiotherapy and leads to poor prognosis in spinal metastases7
Postoperative locoregional recurrence pattern and treatment management of stage pT4 sigmoid colon cancer: a retrospective cohort study7
Quality assurance of radiotherapy in the ongoing EORTC 1420 “Best of” trial for early stage oropharyngeal, supraglottic and hypopharyngeal carcinoma: results of the benchmark case procedure7
Increased risk of cerebrovascular mortality in head and neck cancer survivors aged ≥ 65 years treated with definitive radiotherapy: a population-based cohort study7
Transparency in quality of radiotherapy for breast cancer in the Netherlands: a national registration of radiotherapy-parameters7
Combined effect of dose gradient and rotational error on prescribed dose coverage for single isocenter multiple brain metastases in frameless stereotactic radiotherapy7
Assessing radiation-induced carotid vasculopathy using ultrasound after unilateral irradiation: a cross-sectional study7
Selectively recommend 18F-FDG PET/CT for patients with de novo nasopharyngeal carcinoma in endemic areas7
Long-term outcome of stereotactic brachytherapy with temporary Iodine-125 seeds in patients with WHO grade II gliomas7
Radiotherapy dose–volume parameters predict facial lymphedema after concurrent chemoradiation for nasopharyngeal carcinoma7
Predicting pathological complete response (pCR) after stereotactic ablative radiation therapy (SABR) of lung cancer using quantitative dynamic [18F]FDG PET and CT perfusion: a prospective exploratory 7
The relationship between the radiation dose of pelvic-bone marrow and lymphocytic toxicity in concurrent chemoradiotherapy for cervical cancer7
Technical note: factors affecting dose distribution in the overlap region of two-segment total body irradiation by helical tomotherapy7
External application of liver compresses to reduce fatigue in patients with metastatic cancer undergoing radiation therapy, a randomized clinical trial7
True abscopal effect in a patient with metastatic non-small cell lung cancer7
Intra-fraction displacement of the prostate bed during post-prostatectomy radiotherapy7
Factors associated with long-term survival in gemcitabine-concurrent proton radiotherapy for non-metastatic locally advanced pancreatic cancer: a single-center retrospective study7
Cancer care at the time of the fourth industrial revolution: an insight to healthcare professionals’ perspectives on cancer care and artificial intelligence7
Outcomes of proton therapy for non-small cell lung cancer in patients with interstitial pneumonia6
Protective ileostomy increased the incidence of rectal stenosis after anterior resection for rectal cancer6
High-dose proton beam therapy versus conventional fractionated radiation therapy for newly diagnosed glioblastoma: a propensity score matching analysis6
Direct comparison of low-dose-rate brachytherapy versus radical prostatectomy using the surgical definition of biochemical recurrence for patients with intermediate-risk prostate cancer6
Quantifying the reduction of respiratory motion by mechanical ventilation with MRI for radiotherapy6
Phase I trial of dose-escalated stereotactic radiosurgery (SRS) boost for unfavorable locally advanced oropharyngeal cancer6
Response assessment after stereotactic body radiation therapy for spine and non-spine bone metastases: results from a single institutional study6
Patients with pretreatment leukoencephalopathy and older patients have more cognitive decline after whole brain radiotherapy6
Advancements of radiotherapy for recurrent head and neck cancer in modern era6
3D-printed individualized tooth-borne tissue retraction devices compared to conventional dental splints for head and neck cancer radiotherapy: a randomized controlled trial6
Implementation, adherence, and results of systematic SARS-CoV-2 testing for asymptomatic patients treated at a tertiary care regional radiation oncology network6
18F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapy6
BRAF mutation correlates with worse local–regional control following radiation therapy in patients with stage III melanoma6
Retrospective analysis of recurrence patterns and clinical outcome of grade II meningiomas following postoperative radiotherapy6
Organ motion in linac-based SBRT for glottic cancer6
Correlation between changes of pelvic bone marrow fat content and hematological toxicity in concurrent chemoradiotherapy for cervical cancer6
Health-related quality of life and patient-reported symptoms after postoperative proton beam radiotherapy of cervical and endometrial cancer: 2-year results of the prospective phase II APROVE-trial6
Reduction of inter-observer differences in the delineation of the target in spinal metastases SBRT using an automatic contouring dedicated system6
Dosimetric and radiobiological comparison of simultaneous integrated boost radiotherapy for early stage right side breast cancer between three techniques: IMRT, hybrid IMRT and hybrid VMAT6
Radio-resistance of hypoxic tumors: exploring the effects of oxygen and X-ray radiation on non-small lung cancer cell lines6
Characteristics of locoregional extension of unilateral nasopharyngeal carcinoma and suggestions for clinical target volume delineation6
Real-world outcomes of PD-L1 inhibitors combined with thoracic radiotherapy in the first-line treatment of extensive stage small cell lung cancer6
Lenvatinib with or without stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective study6
30-day mortality in patients treated for brain metastases: extracranial causes dominate6
Stereotactic body radiation therapy for prostate cancer: a study comparing 3-year genitourinary toxicity between CyberKnife and volumetric-modulated arc therapy by propensity score analysis6
Efficacy of concurrent chemoradiotherapy plus Endostar compared with concurrent chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study6
Feasibility study of volumetric modulated arc therapy with Halcyon™ linac for total body irradiation6
CT ventilation image-guided helical Tomotherapy at sparing functional lungs for locally advanced lung cancer: analysis of dose-function metrics and the impact on pulmonary toxicity6
Cochlea sparing optimized radiotherapy for nasopharyngeal carcinoma6
Biologically consistent dose accumulation using daily patient imaging6
0.035609006881714